BillionToOne Inc., a molecular diagnostics company, raised $273.1 million in an upsized US initial public offering, during a US government shutdown that has complicated the listing process.

Molecular diagnostics firm BillionToOne raised $273.1 million in its U.S. initial public offering on Wednesday, pricing its shares above its marketed range.

Guest writer Dr Kun-Yu Wang describes how the development of a tunable MOF illustrates chemistry's potential in mechanical ...

Plastic isn't just everywhere - it's everything. From the food we buy to the cars we drive, the global plastics economy is worth more than $800 billion. But its future hinges on one critical shift: ...

Explore how smart automation enables precise, reproducible workflows in anaerobic microbiome research, improving accuracy and ...

The market surge is driven by Italy's robust public healthcare system, an aging population, and growing demand for early ...

According to Mordor Intelligence, the global companion diagnostics market is valued at USD 8.70 billion in 2025 and is projected to surpass ...

According to Mordor Intelligence, the global companion diagnostics market is valued at USD 8.70 billion in 2025 and is ...